Automation Advantage Rhinostics offers automated swab workflows and decapping integration with high throughput systems, presenting an opportunity to upsell to laboratories seeking scalable sample processing, reduced manual labor, and lower per-sample costs.

Home Collection Upsell The ELEstic and VERIstic collection devices enable at home or clinician-assisted sampling, suggesting sales potential with direct-to-consumer programs, telehealth partners, and mobile collection services aiming to speed specimen intake and broaden testing reach.

High Throughput Fit The 96-well plate, dry shipment compatibility, and 2D barcode tracking align Rhinostics with labs pursuing end-to-end automation, offering cross-sell opportunities to labs currently using or evaluating automated liquid handling and decapping hardware.

Strategic Partnerships Ongoing collaborations with LVL Technologies and academic spinouts indicate readiness for co-development and system integration deals; pursue co-marketing, OEM, or joint-venture arrangements with diagnostic manufacturers and lab equipment vendors.

Early Stage Validation Recent funding activity and product launches (RHINObot, ELEbot, VERIstic) signal growth momentum and investor interest; target expanding clinical and reference lab networks that are early adopters of automated collection and rapid decapping to accelerate deployment.